MariMed Announces Fourth Quarter and Full Year 2023 Earnings Date
NORWOOD, Mass., Feb. 05, 2024 (GLOBE NEWSWIRE) — MariMed Inc. (“MariMed” or the “Company”), (CSE: MRMD), (OTCQX: MRMD), a leading […]
BridgeBio Pharma Announces U.S. Food and Drug Administration (FDA) Acceptance of New Drug Application (NDA) for Acoramidis for the Treatment of Patients with Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
– Accepted with Prescription Drug User Fee Act (PDUFA) action date of November 29, 2024; FDA not currently planning to […]
Microbot Medical Submits an IDE Application to Gain FDA Approval to Commence Its Pivotal Clinical Trial in the US
BRAINTREE, Mass., Feb. 05, 2024 (GLOBE NEWSWIRE) — Microbot Medical Inc. (Nasdaq: MBOT), developer of the LIBERTY® Endovascular Robotic Surgical […]
Verrica Pharmaceuticals Files Lawsuit Against Canadian Drug Manufacturer for False Advertising and Unfair Competition
Lawsuit alleges false and misleading advertising and promotion of unapproved cantharidin-containing drugs by Dormer Laboratories in violation of federal and […]
America’s Car-Mart, Inc. Schedules Release of Third Quarter Fiscal Year 2024 Results and Conference Call
ROGERS, Ark., Feb. 05, 2024 (GLOBE NEWSWIRE) — America’s Car-Mart, Inc. (NASDAQ: CRMT) today announced it will release fiscal 2024 […]
BioRestorative Therapies Presents Preliminary Clinical Data from Phase 2 Study of BRTX-100 in Chronic Lumbar Disc Disease
— Preliminary data includes 26 and 52-week follow-up end points as part of ongoing Phase 2 trial — — Company […]
AMG Reports Financial and Operating Results for the Fourth Quarter and Full Year 2023
Company reports EPS of $5.15, Economic EPS of $6.86 in the fourth quarter of 2023 EPS of […]
TSX News -
Troilus Announces CFO Transition
MONTREAL, Feb. 05, 2024 (GLOBE NEWSWIRE) — Troilus Gold Corp. (TSX: TLG; OTCQX: CHXMF; FRA: CM5R) (“Troilus” or the “Company”), […]
Orchard Therapeutics Announces First Patient Randomized in Registrational Trial of OTL-203 for MPS-I Hurler Syndrome
Gene therapy being developed as a one-time treatment to address the underlying cause of the disease by inserting a functional […]
Nuvini (Nasdaq: NVNI), Announces Its New Board Member and Audit Committee Chair
NEW YORK, Feb. 05, 2024 (GLOBE NEWSWIRE) — Nvni Group Limited (Nasdaq: NVNI) (“Nuvini”), the leading serial acquirer of private […]
